Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RAB8B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TUG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
HIST1H2AB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEPT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BRWD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RIT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
DCAF7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C6orf62 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VPS50 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHSY3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC71L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYEOV - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NR4A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NIPBL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PEX13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKRD35 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMPD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR3190 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on